Medical Education
View as webpage
Be The Match

Forward to a Colleague



Take Action - Sign on to our coalition letter to support HR 4215

Transplant centers continue to lose thousands of dollars on every Medicare patient they treat, creating a future access barrier and an unsustainable financial situation. Many of you have been a part of these advocacy efforts and thousands of letters have been submitted to the U.S. Congress and Centers for Medicare & Medicaid Services (CMS). 

Thanks to your partnership we have been able to introduse legislation Protect Accesss to Cellular Transplant (PACT) Act, which would create a separate payment for donor search and cell acquisition costs. At the same time, we are continuing our advocacy and education efforts with CMS to enable payment for these services on a reasonable cost basis. The current Inpatient Prospective Payment System (IPPS) proposed rule did not address donor search and cell acquisition payment policy, despite thousands of comment letters from transplant centers, patient, caregiver and general advocates across the country. 

We urge transplant centers and other organizations to sign on to our letter to CMS. This will help the Agency understand the potential for a serious Medicare patient access barrier to life-saving allogeneic HCT. Together, we can make our voices heard and protect patient access to care.

Please read our letter and email by Tuesday, June 12th to undersign.

Read our coalition letter arrow


NMDP's Public and Payer Policy team is on Twitter!

NMDP Public and Payer Policy team recently launched a new Twitter account dedicated to all things cellular therapy policy, reimbursement and legislative issues. Follow @BTMPublicPolicy  to stay up to date and join the conversation. Remember to use #BeTheMatchAction to show your advocacy and support!

Follow our new channel

Histocompatability code crosswalk for extended HLA services

If your transplant center is utilizing expanded lab services through NMDP, check out our new Histocompatability CPT Code Crosswalk.

Histocompatability CPT Code Crosswalk >

June 19 is World Sickle Cell DayINES

Supporting clinical trials for those with Sickle Cell Disease.

STRIDE2, or BMT CTN 1503, is a CMS-approved Coverage with Evidence Development (CED) clinical trial (phase II) designed to compare HCT with standard of care in adolescents and young adults with severe sickle cell disease (SCD). However, not all patients have Medicare and many may have Medicaid coverage, which varies significantly between states. NMDP created a new guide for transplant centers that will help you understand patient pathways to clinical trial coverage of HCT for SCD.

Access the STRIDE2 Insurance Guide >


Where can you find us next?

Rachel Glissmann (Public and Payer Policy) and Scott Kerwin (Patient and Health Professional Services) will be exhibiting at the 2018 CMSA Annual Conference & Expo in Chicago, June 19-23. If you are attending, please stop by our booth (#100)!

Education Opportunities

On Demand: Exploring Clinical Trials - Patient Navigation to Increase Access

This webinar is available anytime to health professionals who want to understand patient access to clinical trials for patients with blood cancers or blood disorders—and to help patients find clinical trial information through the Jason Carter Clinical Trials Program.  

Watch the webinar now >

Coming up: Diffuse Large B-cell Lymphoma: Treatment and Support

The goal of this activity is to ensure that members of a multidisciplinary team have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with DLBCL. This webinar is jointly planned with The Leukemia & Lymphoma Society.

Register now >

Forward to a Friend

Please feel free to forward this email to others who would benefit from this information. If this email was forwarded to you, we invite you to subscribe.

If you have any questions or need additional information, please contact the Payer Policy Team at

All of our resources are available on our website:

National Marrow Donor Program, 500 N. 5th Street, Minneapolis, MN 55401
1 (763) 406-5800 | 1 (800) 526-7809 | | Privacy Policy | Terms of Use
Copyright © 2017 National Marrow Donor Program

This e-mail is sent only to individuals who have requested to receive E-communications from NMDP. If this email was forwarded to you, we invite you to subscribe.  If you would like to stop receiving education notices and our clinical e-newsletter, please unsubscribe.

Copyright © 1996-2018 National Marrow Donor Program. All Rights Reserved.